Show simple item record

dc.contributor.authorJindani, A
dc.contributor.authorBorgulya, G
dc.contributor.authorde Patiño, I W
dc.contributor.authorGonzales, T
dc.contributor.authorde Fernandes, RA
dc.contributor.authorShrestha, B
dc.contributor.authorAtwine, D
dc.contributor.authorBonnet, M
dc.contributor.authorBurgos, M
dc.contributor.authorDubash, F
dc.contributor.authorPatel, N
dc.contributor.authorCheckley, AM
dc.contributor.authorHarrison, TS
dc.contributor.authorMitchison, D
dc.date.accessioned2017-01-25T16:17:54Z
dc.date.available2017-01-25T16:17:54Z
dc.date.issued2016-06-01
dc.date.submitted2017-01-19
dc.identifier.citationA Randomised Phase II Trial to Evaluate the Toxicity of High-Dose Rifampicin to Treat Pulmonary Tuberculosis. 2016, 20 (6):832-8 Int. J. Tuberc. Lung Dis.en
dc.identifier.issn1815-7920
dc.identifier.pmid27155189
dc.identifier.doi10.5588/ijtld.15.0577
dc.identifier.urihttp://hdl.handle.net/10144/618772
dc.description.abstractRandomised Phase IIB clinical trial.
dc.language.isoenen
dc.publisherInternational Union Against Tuberculosis and Lung Diseaseen
dc.rightsArchived with thanks to The International Journal of Tuberculosis and Lung Disease: the official journal of the International Union against Tuberculosis and Lung Diseaseen
dc.titleA Randomised Phase II Trial to Evaluate the Toxicity of High-Dose Rifampicin to Treat Pulmonary Tuberculosisen
dc.identifier.journalThe International Union Against Tuberculosis and Lung Disease : the official journal of the International Union against Tuberculosis and Lung Diseaseen
refterms.dateFOA2019-03-04T13:06:36Z
html.description.abstractRandomised Phase IIB clinical trial.


Files in this item

Thumbnail
Name:
Jindani A et al - 2016 - Randomised ...
Size:
288.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record